Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multigate Quality Doppler Profiles and Morphological/Hemodynamic Alterations in Multiple Sclerosis Patients.
Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis.
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.
Teva Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE(R) Patent
Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis.
Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting: Alemtuzumab (BLA 103948\5139) Background Package
Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.
Comparing the biological impact of glatiramer acetate with the biological impact of a generic.
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy.
Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
Fatigue, depression and sleep disturbances in Iranian patients with multiple sclerosis.
Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study.
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level.
Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial.
CNS myelin wrapping is driven by actin disassembly.
Positive year one results from Biogen Idec's Phase 3 advance trial of PLEGRIDY™ (peginterferon beta-1a) presented at AAN meeting
Food and Drug Administration Approval Letter for Alemtuzumab
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment.
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1.
Stress signaling etches heritable marks on chromatin.
Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration.
Substance Name: Amiloride
The potential role of epigenetic modifications in the heritability of multiple sclerosis.

Pages